Vadim V. Negrebetsky

Prof. Vadim V. Negrebetsky

NI Pirogov Russian National Research Medical University
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2012 in Organometallics
Verified
Journal Article
Closed access
ANAlexei A. Nikolin
Alexei A. Nikolin
EKEvgeniya P. Kramarova
Evgeniya P. Kramarova
ASAleksander G. Shipov
Aleksander G. Shipov
YBYuri I. Baukov
Yuri I. Baukov
Vadim V. NegrebetskyVadim V. Negrebetsky
Vadim V. Negrebetsky
PTPeter Geoffrey Taylor
Peter Geoffrey Taylor

15 September 2006 in Journal of Organometallic Chemistry
Verified
Journal Article
Closed access
AKAlexander Korlyukov
Alexander Korlyukov
SPSergey A. Pogozhikh
Sergey A. Pogozhikh
YOYuri E. Ovchinnikov
Yuri E. Ovchinnikov
KLKonstantin Lyssenko
Konstantin Lyssenko
MAMikhail Yu. Antipin
Mikhail Yu. Antipin
YBYuri I. Baukov
Yuri I. Baukov

11 October 2021 in Molecules
Verified
Journal Article
Open access
PDF file
DBDenis Andreevich Borozdenko
Denis Andreevich Borozdenko
AEAiarpi Ezdoglian
Aiarpi Ezdoglian
TSTatiana Shmigol
Tatiana Shmigol
DGDaria Ivanovna Gonchar
Daria Ivanovna Gonchar
DLDmitri Nicolayevich Lyakhmun
Dmitri Nicolayevich Lyakhmun
Yuri BaukovYuri Baukov
Yuri Baukov
We performed an in silico, in vitro, and in vivo assessment of a potassium 2-[2-(2-oxo-4-phenylpyrrolidin-1-yl) acetamido]ethanesulfonate (compound 1) as a potential prodrug for cognitive function improvement in ischemic brain injury. Using in silico methods, we predicted the pharmacological efficacy and possible safety in rat models. In addition, in silico data showed neuroprotective features of compound 1, which were further supported by in vitro experiments in a glutamate excitotoxicity-induced model in newborn rat cortical neuron cultures. Next, we checked whether compound 1 is capable of crossing the blood–brain barrier in intact and ischemic animals. Compound 1 improved animal behavior both in intact and ischemic rats and, even though the concentration in intact brains was low, we still observed a significant anxiety reduction and activity escalation. We used molecular docking and molecular dynamics to support our hypothesis that compound 1 could affect the AMPA receptor function. In a rat model of acute focal cerebral ischemia, we studied the effects of compound 1 on the behavior and neurological deficit. An in vivo experiment demonstrated that compound 1 significantly reduced the neurological deficit and improved neurological symptom regression, exploratory behavior, and anxiety. Thus, here, for the first time, we show that compound 1 can be considered as an agent for restoring cognitive functions.

10 December 2021 in Molecules
Verified
Journal Article
Open access
PDF file
VSVladislav Skarga
Vladislav Skarga
Vadim V. NegrebetskyVadim V. Negrebetsky
Vadim V. Negrebetsky
Yuri BaukovYuri Baukov
Yuri Baukov
MMMikhail V. Malakhov
Mikhail V. Malakhov
More efficient and preferably more convenient and greener synthetic solutions in coumarin scaffold functionalization are in steady demand. The Duff ortho-formylation of unsubstituted umbelliferone was revised in this study. The reaction conditions were optimized based upon data from the literature analysis and resulted in unexpectedly rapid ortho-formylation of umbelliferone, yielding a mixture of ortho-formyl position isomers. Thorough studies on the separation of ortho-formylated umbelliferones using chromatographic and recrystallization methods as well as the evaluation of their solubility in common organic solvents led to complete resolution of 8-formyl- and 6-formylumbelliferones. The precise protocol for simultaneous preparation, extraction, and purification of 8-formyl- and 6-formylumbelliferones is provided, and the prospective studies of biological and pharmacological activities of these compounds are synopsized.

3 November 2022 in Molecules
Verified
Journal Article
Open access
PDF file
EKEugene P. Kramarova
Eugene P. Kramarova
Sophia S. BorisevichSophia S. Borisevich
Sophia S. Borisevich
EKEdward Maratovich Khamitov
Edward Maratovich Khamitov
AKAlexander Korlyukov
Alexander Korlyukov
PDPavel Dorovatovskii
Pavel Dorovatovskii
Vadim V. NegrebetskyVadim V. Negrebetsky
Vadim V. Negrebetsky
The synthesis of the products of the 1,3-propanesultone ring opening during its interaction with amides of pyridinecarboxylic acids has been carried out. The dependence of the yield of the reaction products on the position (ortho-, meta-, para-) of the substituent in the heteroaromatic fragment and temperature condition was revealed. In contrast to the meta- and para-substituted substrates, the reaction involving ortho-derivatives at the boiling point of methanol unexpectedly led to the formation of a salt. On the basis of spectroscopic, X-Ray, and quantum-chemical calculation data, a model of the transition-state, as well as a mechanism for this alkylation reaction of pyridine carboxamides with sultone were proposed in order to explain the higher yields obtained with the nicotinamide and its N-methyl analog compared to ortho or meta parents. Based on the analysis of ESP maps, the positions of the binding sites of reagents with a potential complexing agent in space were determined. The in silico evaluation of possible biological activity showed that the synthetized compounds revealed some promising pharmacological effects and low acute toxicity.

1 October 2018 in Journal of Organometallic Chemistry
Verified
Journal Article
Closed access
Vadim V. NegrebetskyVadim V. Negrebetsky
Vadim V. Negrebetsky
EKEugeniya P. Kramarova
Eugeniya P. Kramarova
ASAleksander G. Shipov
Aleksander G. Shipov
YBYuri I. Baukov
Yuri I. Baukov
AKAlexander A. Korlyukov
Alexander A. Korlyukov
SBSergey Yu Bylikin
Sergey Yu Bylikin